A part of Ball State Unversity's award winning College of Communication, Information, and Media, Byte is a student-run, ...

The Fullerton Police Department will conduct a driving under the influence (DUI)/driver’s license Checkpoint on February 20th ...

Oncotelic Therapeutics, a leader in RNA-based therapeutics, is pleased to announce that Vuong Trieu, Ph.D., Chairman & CEO, will be delivering a featured presentation at the SWCR 2025 Conference on ...

Boston-based Bicara launched in 2021 and is a subsidiary of Indian pharma company Biocon, which provided its seed funding. Bicara is also studying ficerafusp alfa, its lead candidate, in anal cancer ...

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

James F. Oliviero III, the CEO, President, and Director of Checkpoint Therapeutics , Inc. (NASDAQ:CKPT), recently sold shares ...

Immune checkpoint blockers (ICBs ... NGM Biopharmaceuticals, Amgen, Mirati Therapeutics, Kaleido Biosciences, Elevation Oncology, Daiichi Sankyo/Lilly, Regeneron, AbbVie/Genentech, Arcus Biosciences ...

William Garrett Gray, the Chief Financial Officer of Checkpoint Therapeutics , Inc. (NASDAQ:CKPT), recently sold 74,110 shares of the company’s common stock. The shares were sold at a weighted average ...

This approach aims to improve treatment for patients with this highly aggressive and treatment-resistant type of breast ...

Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical-stage biotechnology company pioneering innovative cancer and viral infection treatments, today announced the ...